Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Subject: Lexibook: Q3 2024-25 Revenue at €39.3M, up 31.1%. Over 9 months, revenue increases by 23.43%.
-
Pulse Seismic Inc. Reports 2024 Financial Results and Declares Regular and Special Dividends
-
DBGI Announces Pricing of $7.5 Million Public Offering of Units of Common Stock and/or Pre-Funded Warrants and Warrants
-
InflaRx Announces Pricing of $30 Million Public Offering of Ordinary Shares and Pre-Funded Warrants
-
Early Warning News Release
-
GoldHaven Announces Closing of Private Placement
-
Yerbaé Expands Georgia Distribution Through Savannah Distributing Company Inc. and Announces Grant of Equity Incentives
-
BE Resources Announces Application for Resumption of Trading and Corporate Updates
-
EzFill Holdings Announces Pricing of $15 Million Public Offering and Closing of Share Exchange with NextNRG
-
Theratechnologies Resumes Distribution of EGRIFTA SV®
-
MercadoLibre, Inc. to Report Fourth Quarter 2024 Financial Results
-
Oculis Announces Pricing of $100 Million Oversubscribed Offering of Ordinary Shares
-
CoreAI Unveils Revolutionary AI-Powered Blockchain Platform to Simplify dApp Development
-
Company Distilling Appoints Cassie Halley as Director of Marketing & Retail Operations
-
FEMSA Schedules Conference Call to Discuss Fourth Quarter and Full Year 2024 Financial Results
-
Ryoncil® FDA Approval and Market Launch Highlighted at Tandem Transplantation Meetings
-
Fortis Inc. Announces Second Quarter Dividends – 2025
-
Western Announces Fourth Quarter and Fiscal 2024 Results
-
Parker Scheduled to Present at Citi’s 2025 Global Industrial Tech and Mobility Conference on February 20 at 11:20 a.m. Eastern Time
-
THE GRANITE GROUP OPENS NEWEST BRANCH IN ELLSWORTH, ME
-
b1BANK Announces Senna Bayasgalan as Chief Marketing Officer
-
PDF Solutions® Announces Record 2024 Fourth Quarter and Full Year Total Revenues
-
In Hawaii, Ninth Circuit Hears Oral Argument in NCLA Case Against SEC’s Illegal Gag Rule
-
Fairfax Financial Holdings Limited: Financial Results for the Year Ended December 31, 2024
-
MINILUXE ANNOUNCES CFO TRANSITION
-
Dundee Precious Metals Achieves Record Financial Results in 2024; Three-Year Outlook Highlights Focus on Next Phase of Growth
-
CAPREIT Reports Fourth Quarter and Year End 2024 Results
-
Dundee Precious Metals Declares Dividend
-
GINSMS Announces Financial Results for the Three and Twelve Months Ended December 31, 2024 and Provides Financial Forecasts for Year 2025
-
Midland Exploration Announces the Grant of Options
-
Air Marshal Association recognized as Federal Air Marshal union and leads effort to separate from the TSA
-
Profound Medical to Release Fourth Quarter and Full Year 2024 Financial Results on March 6 – Conference Call to Follow
-
Alamos Gold Announces Development Plan for High-Return Burnt Timber and Linkwood Satellite Deposits
-
Interfor Reports Q4’24 Results
-
Matinas BioPharma Announces Agreement for the Acquisition of Preferred Stock and Appointment of Dr. Robin L. Smith to the Board of Directors
-
Island Passage Exploration Summarizes 2024 and Launches 2025 Exploration Campaign on Bougainville Island, Papua New Guinea
-
Eric Hollifield Scholarship for Student-Athletes Opens Applications for 2025, Championing Excellence in Sports and Academics
-
Increased Funding on Commercial Buildings Approved for Texas C-PACE Projects
-
Statement from John W. Mitchell, IPC President and CEO, on U.S. Tariffs and Global Trade
-
Outset Medical Announces Resolution of Warning Letter
-
NeuroPace Announces Proposed Public Offering of $65 Million of Common Stock
-
Tevogen Bio CEO Congratulates RFK Jr. on His Confirmation as Secretary of the HHS; Echoes Commitment to Innovation and Affordability for Americans
-
Orrstown Financial Services, Inc. Announces Promotion of Adam Metz to Senior Executive Vice President and Chief Operating Officer
-
Cenovus to hold fourth-quarter and full-year conference call and webcast on February 20
-
Allogene Therapeutics Announces Publication of Durable Response Data from Phase 1 ALPHA/ALPHA2 Trials of the Allogeneic CAR T Cemacabtagene Ansegedleucel/ALLO-501 in Relapsed/Refractory Large B-Cell L
-
Precision Optics Reports Second Quarter Fiscal Year 2025 Financial Results
-
Aptose Enters into $25 Million Committed Equity Facility and Establishes New At-The-Market Facility
-
Credit Acceptance Announces Conditional Notice of Redemption for Outstanding Senior Notes Due 2026
-
GoHealth to Announce Fourth Quarter 2024 Results on February 27, 2025
-
Aureus Greenway Holdings Inc. Announces the Closing of its Initial Public Offering

